Sanofi and Regeneron expand antibody deal with $1 billion upfront
Regeneron will lead research and development, Sanofi will lead commercial efforts, and profits would be split evenly.
Intelligence
The parties
Activity
Regeneron will lead research and development, Sanofi will lead commercial efforts, and profits would be split evenly.
Intelligence
Activity